Inactive Instrument

Other languages Cadila Healthcare Limited NSE India S.E.

Equities

INE010B01019

End-of-day quote NSE India S.E. Other stock markets
- ^INR	-

Apr. 26	Weak March Quarter Earnings Weigh Down Indian Equities on Friday	MT
Apr. 26	Zydus Lifesciences Gets US FDA's Final Approval for Generic Acne Cream	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Weak March Quarter Earnings Weigh Down Indian Equities on Friday	Apr. 26
Zydus Lifesciences Gets US FDA's Final Approval for Generic Acne Cream	Apr. 26
Zydus Lifesciences Gets 10 Observations from US FDA After Jarod, India Manufacturing Site Inspection	Apr. 24
Zydus Lifesciences Limited Announces New Drug Application of Zydus' Innovative Drug Desidustat Tablets by China Medical System Holdings Limited Accepted in China	Apr. 23
Zydus Lifesciences Limited Launches Mirabegron Extended-Release Tablets in the U.S	Apr. 22
Zydus Receives Approval from WHO International Non-Proprietary Names for Usnoflast as Recommended Name for ZYIL1	Apr. 01
Zydus Gets Four Observations from US FDA for Oncology Injectable Plant	Mar. 28
Zydus Lifesciences Limited Receives Tentative Approval from USFDA for Letermovir Tablets, 240 Mg and 480 Mg	Mar. 23
Zydus Lifesciences Gets US FDA's Final Nod for Finasteride and Tadalafil Capsules	Mar. 17
Zydus Lifesciences Limited Receives Final Approval from USFDA and 180 Days CGT Exclusivity for Finasteride and Tadalafil Cap Capsules	Mar. 16
Zydus Lifesciences Gets US FDA Final Nod for Chlorpromazine Hydrochloride Injection; Shares Jump 3%	Mar. 14
Zydus Receives Final Approval from the USFDA for Chlorpromazine Hydrochloride Injection USP, 25 mg/mL and 50 mg/2 mL (25 mg/mL), Single-Dose Vials	Mar. 14
Zydus Receives Tentative Approval from the USFDA for Edaravone Injection, 30 mg/100 mL (0.3 mg/mL), Single-Dose Vial	Mar. 14
Zydus Lifesciences Launches Generic Cancer Drug Ibyra in India	Mar. 13
Zydus Lifesciences Limited Launches IBYRA, the Generic Version of Olaparib	Mar. 13
Zydus Lifesciences Gets US FDA's EIR for Ahmedabad, India Unit's Inspection	Mar. 11
EXCLUSIVA-Eli Lilly podría lanzar un fármaco contra la obesidad en India el próximo año: presidente ejecutivo	Feb. 28
Zydus Lifesciences Forms UAE-Based Arm	Feb. 22
Zydus Lifesciences Limited Announces Incorporation of Wholly Owned Subsidiary Company	Feb. 22
Zydus Lifesciences Gets US FDA Final Approval for Generic Chest Pain Drug	Feb. 16

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Cadila Healthcare Limited NSE India S.E.

Equities

INE010B01019

Other languages

Filters